Diabetic Retinopathy: A Comprehensive Clinical and Treatment Approach
PDF (Português (Brasil))

Keywords

Diabetic Retinopathy; Clinic; Treatment; Diabetes Mellitus; Eye Complications.

How to Cite

Tochetto, L., Braz Alves, A. B., Nunes Junior, C. A., Bessa Silveira Filho, M. O., Lassance Moreira de Abreu, G., Alvarenga Riveros, M. C., de Souza Zampieri, B., Prauchner Padilha, A., Novaes Teixeira Garcia Ruiz, J., & Alves de Souza, T. (2024). Diabetic Retinopathy: A Comprehensive Clinical and Treatment Approach. Brazilian Journal of Implantology and Health Sciences, 6(10), 4298–4306. https://doi.org/10.36557/2674-8169.2024v6n10p4298-4306

Abstract

Diabetic retinopathy (DR) is a significant complication of diabetes mellitus, characterized by progressive damage to the retinal blood vessels that can lead to blindness. This condition is a critical public health problem, with approximately one-third of individuals with diabetes affected globally, requiring early diagnosis and intervention to prevent serious ocular complications. This article aims to review the clinical manifestations of DR and discuss current therapeutic approaches, emphasizing innovations in diagnostic methods and new management strategies that influence the treatment of DR in clinical practice. A literature review was used focusing on experimental and non-experimental studies addressing the clinical and therapeutic aspects of DR. Data were extracted from databases such as PubMed and SciELO, with meticulous selection to include relevant articles and exclude non-pertinent or unavailable studies in full. DR is influenced by multiple risk factors, including inadequate glycemic control, hypertension, and lifestyle factors. Studies indicate that strict glycemic control significantly reduces the risk of ocular complications. Technological advances, such as optical coherence tomography and artificial intelligence systems, have improved diagnostic accuracy, facilitating more timely interventions. Treatment has evolved to include anti-VEGF therapies and surgical options, while the management approach requires a multidisciplinary effort. DR requires a multidisciplinary and integrated treatment approach that combines rigorous risk factor management, diagnostic advances, and targeted therapies. Patient education and engagement in self-care are critical for therapeutic success. Public health policies should focus on improving access to diagnostic and treatment services, especially in less developed regions, to address the increasing global prevalence of diabetes and its complications. Continuous collaboration among health professionals is essential to improve health outcomes and mitigate the burden of DR.

https://doi.org/10.36557/2674-8169.2024v6n10p4298-4306
PDF (Português (Brasil))

References

AMERICAN DIABETES ASSOCIATION. Standards of Medical Care in Diabetes—2022. Diabetes Care, v.45, Supplement_1, 2022.

BOYER, D. S. et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology, v.121, n.10, p.1904-1914, 2014.

CABELLINO, Luíza Fricks et al. Retinopatia Diabética: uma revisão sistemática, do panorama da doença ao tratamento. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 7, p. 1322-1334, 2024.

CORSINI, Sarah Lindsen Souza et al. Retinopatia Diabética-uma revisão abrangente sobre a etiologia, epidemiologia, diagnóstico, tratamento farmacológico e tratamento cirúrgico. Brazilian Journal of Health Review, v. 6, n. 5, p. 23704-23713, 2023.

DA CUNHA CORRÊA, Marianna et al. Padrão dos métodos diagnósticos oftalmológicos usados para o diagnóstico precoce de retinopatia diabética: uma revisão de literatura. Revista Eletrônica Acervo Médico, v. 5, p. e9925-e9925, 2022.

DA SILVA, Simone Nascimento et al. Retinopatia em pacientes diabéticos: fatores de risco importantes. Revista JRG de Estudos Acadêmicos, v. 6, n. 13, p. 134-149, 2023.

DCCT RESEARCH GROUP. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine, v.329, n.14, p.977-986, 1993.

DE AZEVEDO KLEINSCHMITT, Beatriz et al. Retinopatia diabética: uma revisão abrangente sobre etiologia, epidemiologia, diagnóstico, tratamento farmacológico e cirúrgico. Brazilian Journal of Health Review, v. 7, n. 2, p. e68476-e68476, 2024.

DE CARLO, T. E. et al. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology, v.122, n.6, p.1228-1238, 2016.

DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK. Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema. The New England Journal of Medicine, v.372, n.13, p.1193-1203, 2015.

EARLY TREATMENT DIABETIC RETINOPATHY STUDY RESEARCH GROUP. Photocoagulation for diabetic macular edema. Archives of Ophthalmology, v.103, n.12, p.1796-1806, 1985.

EL-BATARNY, A. M. ILM peeling in diabetic macular edema: a prospective randomised study. Graefe's Archive for Clinical and Experimental Ophthalmology, v.246, n.5, p.641-646, 2008.

FONG, D. S. et al. Retinopathy in diabetes. Diabetes Care, v.27, suppl.1, p.s84-s87, 2004.

GALVÃO, Fernanda Mendonça et al. Prevalência e fatores de risco para retinopatia diabética em pacientes diabéticos atendidos por demanda espontânea: um estudo transversal. Revista brasileira de oftalmologia, v. 80, n. 3, p. e0006, 2021.

GULSHAN, V. et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA, v.316, n.22, p.2402-2410, 2016.

IDF DIABETES ATLAS. 10th ed. Brussels, Belgium: International Diabetes Federation, 2021.

LA COUR, M. et al. Pars plana vitrectomy for diabetic retinopathy. Acta Ophthalmologica, v.97, n.1, p.10-15, 2019.

SCANLON, P. H. The English national screening programme for diabetic retinopathy 2003–2016. Acta Diabetologica, v.54, n.6, p.515-525, 2017.

TANURI, Filipe Duarte et al. Retinopatia Diabética: Prevenção e Tratamento: Um exame das medidas de prevenção, monitoramento e opções terapêuticas para pacientes com retinopatia diabética. Brazilian Journal of Implantology and Health Sciences, v. 5, n. 5, p. 1451-1464, 2023.

UKPDS GROUP. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. The Lancet, v.352, n.9131, p.837-853, 1998.

WELLS, J. A. et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. Ophthalmology, v.123, n.6, p.1351-1359, 2016.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Lucas Tochetto, Ana Beatriz Braz Alves, Carlos Augusto Nunes Junior, Miguel Otávio Bessa Silveira Filho, Guilherme Lassance Moreira de Abreu, Maria Clara Alvarenga Riveros, Bruno de Souza Zampieri, Arthur Prauchner Padilha, Jullia Novaes Teixeira Garcia Ruiz, Thiago Alves de Souza

Downloads

Download data is not yet available.
1 1